Glenmark Pharmaceuticals Limited — Others, 23-05-2025: Appointment

Glenmark Pharmaceuticals has announced a board meeting approving the appointment of Mr. Anurag Mantri as Executive Director and Global CFO for a five-year term starting 27 May 2025, subject to shareholder approval. He succeeds Mr. V.S. Mani, who opted for early retirement. With over 30 years of experience in finance and strategy from roles at Jindal Stainless and HCL Technologies, Anurag will also join the Risk Management Committee. This leadership change enhances Glenmark’s financial oversight and supports its strategic growth plans.